Cargando…
Cost or revenue: is diabetes prevention doomed due to misalignment of incentives?
Autores principales: | Mainous 3rd, Arch G, Yadav, Sandhya, Xie, Zhigang, Huo, Jinhai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7032896/ https://www.ncbi.nlm.nih.gov/pubmed/32148736 http://dx.doi.org/10.1136/fmch-2019-000274 |
Ejemplares similares
-
Physicians should declare financial incentives for recruiting minority ethnic patients into clinical trials
por: Mainous, Arch G
Publicado: (2014) -
Misalignment of Stakeholder Incentives in the Opioid Crisis
por: Boloori, Alireza, et al.
Publicado: (2020) -
Associations of patient-centered medical home with quality of care, patient experience, and health expenditures: A STROBE-compliant cross-sectional study
por: Xie, Zhigang, et al.
Publicado: (2021) -
Translating molecular medicine into clinical tools: doomed to fail by neglecting basic preanalytical principles
por: Jung, Klaus, et al.
Publicado: (2009) -
This Week In Doom
Publicado: (2009)